RVL Pharmaceuticals - RVLP Stock Forecast, Price & News

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for RVL Pharmaceuticals in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" RVLP shares.
View RVLP analyst ratings or view top-rated stocks.

RVL Pharmaceuticals' stock was trading at $1.17 at the beginning of the year. Since then, RVLP stock has increased by 36.8% and is now trading at $1.60.
View the best growth stocks for 2022 here.

RVL Pharmaceuticals is scheduled to release its next quarterly earnings announcement on Thursday, August 11th 2022.
View our RVLP earnings forecast.

RVL Pharmaceuticals will be holding an earnings conference call on Thursday, August 11th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link.

RVL Pharmaceuticals plc (NASDAQ:RVLP) released its quarterly earnings results on Thursday, May, 12th. The company reported ($0.13) earnings per share for the quarter, topping the consensus estimate of ($0.25) by $0.12. The business earned $21.44 million during the quarter, compared to analyst estimates of $7.20 million. RVL Pharmaceuticals had a negative net margin of 163.45% and a negative trailing twelve-month return on equity of 100.83%.

RVL Pharmaceuticals trades on the NASDAQ under the ticker symbol "RVLP."

RVL Pharmaceuticals' stock is owned by a number of retail and institutional investors. Top institutional shareholders include Marietta Wealth Management LLC (0.14%).

Shares of RVLP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of RVLP stock can currently be purchased for approximately $1.60.

RVL Pharmaceuticals (NASDAQ:RVLP) has a market capitalization of $133.68 million and generates $17.50 million in revenue each year. The company earns $-64,920,000.00 in net income (profit) each year or ($0.88) on an earnings per share basis.

RVL Pharmaceuticals employs 156 workers across the globe.

RVL Pharmaceuticals' mailing address is 400 Crossing Blvd, Bridgewater, New Jersey 08807-2863. The official website for the company is www.osmotica.com. The company can be reached via phone at (908) 809-1300 or via email at lwilson@insitecony.com.